ORIGINAL ARTICLE
Fat mass and obesity-associated protein expression in colorectal cancer and its influence on the biological behaviour of colorectal cancer cells
More details
Hide details
1
Department of Clinincal Laboratory, Quanzhou First Hospital Affiliated to Fujian Medical University, Quanzhou, Fujian, China
2
Clinical Laboratory, Fujian Maternity and Child Health Hospital, Fuzhou, Fujian, China
Submission date: 2024-07-25
Acceptance date: 2024-10-02
Publication date: 2024-12-30
Pol J Pathol 2024;75(4):343-352
KEYWORDS
TOPICS
ABSTRACT
Fat mass and obesity-associated protein (FTO) was the earliest discovered m6A RNA demethylase. Previous studies have indicated that m6A modifications significantly influence the development, progression, and prognosis of various cancers. This study aimed to explore the role of FTO overexpression in colorectal cancer development, as well as its biological functions. Expression levels of FTO mRNA and protein in colorectal cancer and adjacent non-cancerous tissues were assessed using RT-PCR and immunohistochemistry. FTO overexpression was achieved by transiently transfecting an FTO overexpression plasmid into the HCT15 SW480 colorectal cancer cell line. The impact of this overexpression on the cells was evaluated using real-time fluorescence quantitative PCR, CCK8 proliferation assays, colony formation assays, scratch healing assays, and transwell migration and invasion assays. RT-PCR and immunohistochemistry demonstrated negligible or low FTO mRNA and protein expression in adjacent non-cancerous tissues, while high expression levels were observed in cancerous tissues. FTO overexpression in the HCT15 SW480 cell line significantly increased FTO mRNA levels compared to the control group. CCK8 assays indicated that cell proliferation was significantly higher in the FTO overexpressing group than in the control group. Colony formation assays revealed an increased number of colonies in the FTO group compared to controls. Scratch healing assays showed enhanced cell migration in the FTO group relative to controls. Transwell assays demonstrated a significant increase in invasive cell numbers in the FTO group compared to controls. In conclusion, FTO is highly expressed in colorectal cancer tissues, and its overexpression promotes proliferation and migration of colorectal cancer cells, underscoring its critical oncogenic role in this cancer type.
REFERENCES (15)
1.
Jia G, Fu Y, Zhao X, et al. N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO. Nat Chem Biol 2011; 7: 885-887.
2.
Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209-249.
3.
Tan Z, Shi S, Xu J, et al. RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m(6)A-YTHDF2-dependent manner. Oncogene 2022; 41: 2860-2872.
4.
Wang D, Qu X, Lu W, et al. N(6)-methyladenosine RNA demethylase FTO promotes gastric cancer metastasis by down-regulating the m6A methylation of ITGB1. Front Oncol 2021; 11: 681280. DOI: 10.3389/fonc.2021.681280.
5.
Zhou Y, Wang Q, Deng H, et al. N6-methyladenosine demethylase FTO promotes growth and metastasis of gastric cancer via m(6)A modification of caveolin-1 and metabolic regulation of mitochondrial dynamics. Cell Death Dis 2022; 13: 72. DOI: 10.1038/s41419-022-04503-7.
6.
Liu S, Huang M, Chen Z, et al. FTO promotes cell proliferation and migration in esophageal squamous cell carcinoma through up-regulation of MMP13. Exp Cell Res 2020; 389: 111894. DOI: 10.1016/j.yexcr.2020.111894.
7.
Li J, Han Y, Zhang H, et al. The m6A demethylase FTO promotes the growth of lung cancer cells by regulating the m6A level of USP7 mRNA. Biochem Biophys Res Commun 2019; 512: 479-485.
8.
Zhang L, Wan Y, Zhang Z, et al. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway. RNA Biol 2021; 18: 1265-1278.
9.
Yang S, Wei J, Cui YH, et al. m(6)A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade. Nat Commun 2019; 10: 2782. DOI: 10.1038/s41467-019-10669-0.
10.
Huang H, Wang Y, Kandpal M, et al. FTO-dependent N (6)-methyladenosine modifications inhibit ovarian cancer stem cell self-renewal by blocking cAMP signaling. Cancer Res 2020; 80: 3200-3214.
11.
Huang J, Sun W, Wang Z, et al. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner. J Exp Clin Cancer Res 2022; 41: 42. DOI: 10.1186/s13046-022-02254-z.
12.
Yue C, Chen J, Li Z, et al. microRNA-96 promotes occurrence and progression of colorectal cancer via regulation of the AMPK-2-FTO-m6A/MYC axis. J Exp Clin Cancer Res 2020; 39: 240. DOI: 10.1186/s13046-020-01731-7.
13.
Zou D, Dong L, Li C, et al. The m(6)A eraser FTO facilitates proliferation and migration of human cervical cancer cells. Cancer Cell Int 2019; 19: 321. DOI: 10.1186/s12935-019-1045-1.
14.
Wang F, Hu Y, Wang H, et al. LncRNA FTO-IT1 promotes glycolysis and progression of hepatocellular carcinoma through modulating FTO-mediated N6-methyladenosine modification on GLUT1 and PKM2. J Exp Clin Cancer Res 2023; 42: 267. DOI: 10.1186/s13046-023-02847-2.
15.
Ruan DY, Li T, Wang YN, et al. FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis. Oncogene 2021; 40: 5168-5181.